Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Shares Outstanding (2021 - 2026)

Cingulate's (CINGW) quarterly Shares Outstanding (Entity) came in at $13.9 million in Q2 2026, up 184.19% on a YoY basis from $4.9 million in Q2 2025, and up 174.86% quarter-over-quarter from $5.1 million in Q4 2025.

Analysis

Cingulate (CINGW) Shares Outstanding (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Shares Outstanding (Entity) for 6 consecutive years, with $13.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 184.19% year-over-year to $13.9 million; the trailing twelve-month figure through Jun 2026 stood at $13.9 million (up 184.19% YoY), and the FY2025 full-year result was $5.1 million, up 231.54% from the prior year.
  • Shares Outstanding (Entity) rose to $13.9 million in Q2 2026 per CINGW's latest filing, from $5.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $13.9 million in Q2 2026 and bottomed at $47121.0 in Q1 2022.
  • Historically, Shares Outstanding (Entity) has averaged $2.3 million across 5 years, with a median of $417522.0 in 2024.
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) changed 0.0% in 2023, then jumped 2339.42% in 2024.
  • Over 5 years, Shares Outstanding (Entity) stood at $47121.0 in 2022, then soared by 60.08% to $75432.0 in 2023, then surged by 1921.42% to $1.5 million in 2024, then soared by 231.54% to $5.1 million in 2025, then surged by 174.86% to $13.9 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $13.9 million, $5.1 million, and $6.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 644.70 Bn 623.94 Bn 17.26 Bn 2.41 Bn
2 AbbVie 441.16 Bn 434.59 Bn 12.70 Bn 1.77 Bn
3 Merck 364.92 Bn 357.78 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 266.48 Bn 258.79 Bn 11.24 Bn 1.94 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn 5.70 Bn
6 Sanofi 52.53 Bn 45.15 Bn 10.79 Bn 1.22 Bn
7 Revolution Medicines 44.20 Bn 44.20 Bn - 210.89 Mn
8 Incyte 25.27 Bn 20.74 Bn 1.57 Bn 200.38 Mn
9 United Therapeutics 21.44 Bn 18.78 Bn 683.80 Mn 42.60 Mn
10 Cingulate 100,214.03 100,214.03 - 13.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.19 Mn
Dec 31, 2025 5.06 Mn
Sep 30, 2025 5.43 Mn
Jun 30, 2025 4.39 Mn
Mar 31, 2025 3.65 Mn
Dec 31, 2024 1.52 Mn
Sep 30, 2024 1.77 Mn
Jun 30, 2024 586,313.00
Mar 31, 2024 412,109.00
Dec 31, 2023 75,432.00
Sep 30, 2023 82,358.00
Jun 30, 2023 48,726.00
Mar 31, 2023 47,121.00
Dec 31, 2022 47,121.00
Sep 30, 2022 47,121.00
Jun 30, 2022 47,121.00
Mar 31, 2022 47,121.00
Dec 31, 2021 30,889.00